DK1355918T3 - Rekombinant beskyttelsesprotein af streptococcus pneumoniae - Google Patents
Rekombinant beskyttelsesprotein af streptococcus pneumoniaeInfo
- Publication number
- DK1355918T3 DK1355918T3 DK01996301.6T DK01996301T DK1355918T3 DK 1355918 T3 DK1355918 T3 DK 1355918T3 DK 01996301 T DK01996301 T DK 01996301T DK 1355918 T3 DK1355918 T3 DK 1355918T3
- Authority
- DK
- Denmark
- Prior art keywords
- streptococcus pneumoniae
- protective protein
- ppp
- acid sequences
- present
- Prior art date
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 title abstract 2
- 230000001681 protective effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25884100P | 2000-12-28 | 2000-12-28 | |
PCT/US2001/049650 WO2002053761A2 (en) | 2000-12-28 | 2001-12-28 | Recombinant protective protein from $i(streptococcus pneumoniae) |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1355918T3 true DK1355918T3 (da) | 2011-05-16 |
DK1355918T5 DK1355918T5 (da) | 2012-02-20 |
Family
ID=22982345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01996301.6T DK1355918T5 (da) | 2000-12-28 | 2001-12-28 | Rekombinant beskyttelsesprotein af streptococcus pneumoniae |
Country Status (15)
Country | Link |
---|---|
US (4) | US7118756B2 (da) |
EP (2) | EP1355918B9 (da) |
JP (2) | JP4445200B2 (da) |
KR (1) | KR20030074680A (da) |
CN (1) | CN100422210C (da) |
AT (1) | ATE501161T1 (da) |
AU (1) | AU2002227450B2 (da) |
BR (1) | BR0116756A (da) |
CA (1) | CA2432426A1 (da) |
DE (1) | DE60144198D1 (da) |
DK (1) | DK1355918T5 (da) |
ES (1) | ES2359625T3 (da) |
IL (1) | IL155726A0 (da) |
MX (1) | MXPA03005386A (da) |
WO (1) | WO2002053761A2 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60144198D1 (de) * | 2000-12-28 | 2011-04-21 | Wyeth Llc | Rekombinantes schutzprotein aus streptococcus pneumoniae |
MXPA03009415A (es) | 2001-04-16 | 2004-01-29 | Wyeth Corp | ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS. |
KR101730748B1 (ko) | 2005-04-08 | 2017-04-26 | 와이어쓰 엘엘씨 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US8808707B1 (en) | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
CN101553501A (zh) | 2006-10-26 | 2009-10-07 | 诺沃-诺迪斯克有限公司 | Il-21变种 |
KR102057217B1 (ko) | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
KR20140075201A (ko) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
KR20140075196A (ko) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
EP3058362B1 (en) * | 2013-10-18 | 2019-01-02 | Dr. Reddy's Laboratories Limited | In-vitro method for determining fate of polypeptide variant |
US11708411B2 (en) | 2013-12-20 | 2023-07-25 | Wake Forest University Health Sciences | Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines |
CN109862908B (zh) | 2016-08-05 | 2023-05-02 | 圣诺菲·帕斯图尔公司 | 多价肺炎球菌多糖-蛋白质缀合物组合物 |
MX2019001341A (es) | 2016-08-05 | 2019-07-04 | Sanofi Pasteur Inc | Composicion de conjugado de polisacarido neumococico multivalente-proteina. |
CN110225757A (zh) | 2017-01-31 | 2019-09-10 | 默沙东公司 | 由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法 |
KR20200051004A (ko) | 2017-09-07 | 2020-05-12 | 머크 샤프 앤드 돔 코포레이션 | 폐렴구균 폴리사카라이드 및 면역원성 폴리사카라이드-담체 단백질 접합체에서의 그의 용도 |
CA3084436A1 (en) | 2017-12-06 | 2019-07-18 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
AU2019401535B2 (en) | 2018-12-19 | 2023-12-14 | Merck Sharp & Dohme Llc | Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
WO2021021729A1 (en) | 2019-07-31 | 2021-02-04 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same |
TW202245835A (zh) | 2021-02-04 | 2022-12-01 | 美商默沙東有限責任公司 | 用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物 |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US425330A (en) * | 1890-04-08 | Shutter-fastener | ||
US4367110A (en) | 1979-07-02 | 1983-01-04 | Toppan Printing Co. | Decorative laminate and a manufacturing method therefor |
US4452901A (en) | 1980-03-20 | 1984-06-05 | Ciba-Geigy Corporation | Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays |
US4358535A (en) | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology |
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US4425330A (en) * | 1981-05-20 | 1984-01-10 | Cornell Research Foundation, Inc. | Bovine mastitis vaccine and method for detecting efficacy thereof |
US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
DE3424893A1 (de) | 1984-07-06 | 1986-02-06 | Agfa-Gevaert Ag, 5090 Leverkusen | Photographisches silberhalogenidaufzeichnungsmaterial |
GB8424757D0 (en) | 1984-10-01 | 1984-11-07 | Pasteur Institut | Retroviral vector |
FR2573436B1 (fr) | 1984-11-20 | 1989-02-17 | Pasteur Institut | Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins |
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
US4666829A (en) | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
WO1989007150A1 (en) | 1988-02-05 | 1989-08-10 | The Trustees Of Columbia University In The City Of | Retroviral packaging cell lines and processes of using same |
EP0432216A1 (en) | 1988-09-01 | 1991-06-19 | Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
US5354844A (en) | 1989-03-16 | 1994-10-11 | Boehringer Ingelheim International Gmbh | Protein-polycation conjugates |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
US5266477A (en) * | 1990-02-02 | 1993-11-30 | Pitman-Moore, Inc. | Monoclonal antibodies which differentiate between native and modified porcine somatotropins |
US5053934A (en) | 1990-02-09 | 1991-10-01 | Krebs Juergen | Optical arrangement for high-powered diaprojectors |
CA2039921A1 (en) | 1990-04-16 | 1991-10-17 | Xandra O. Breakefield | Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
WO1991018088A1 (en) | 1990-05-23 | 1991-11-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Adeno-associated virus (aav)-based eucaryotic vectors |
BR9106879A (pt) | 1990-09-25 | 1993-07-20 | Cantab Pharma Res | Virus mutuante nao retroviral,uso do mesmo,vacina e processo de manufaturar umvirus mutante |
US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
US5290393A (en) * | 1991-01-31 | 1994-03-01 | Nichia Kagaku Kogyo K.K. | Crystal growth method for gallium nitride-based compound semiconductor |
JP2666228B2 (ja) * | 1991-10-30 | 1997-10-22 | 豊田合成株式会社 | 窒化ガリウム系化合物半導体発光素子 |
US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
US6015562A (en) | 1992-09-22 | 2000-01-18 | American Cyanamid Company | Targeted forms of methyltrithio antitumor agents |
JPH06120218A (ja) * | 1992-10-02 | 1994-04-28 | Miyazaki Oki Electric Co Ltd | 半導体素子の金属配線 |
US5578839A (en) * | 1992-11-20 | 1996-11-26 | Nichia Chemical Industries, Ltd. | Light-emitting gallium nitride-based compound semiconductor device |
AU680459B2 (en) | 1992-12-03 | 1997-07-31 | Genzyme Corporation | Gene therapy for cystic fibrosis |
WO1994021807A2 (en) | 1993-03-19 | 1994-09-29 | Cantab Pharmaceuticals Research Limited | Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
DE69433926T2 (de) * | 1993-04-28 | 2005-07-21 | Nichia Corp., Anan | Halbleitervorrichtung aus einer galliumnitridartigen III-V-Halbleiterverbindung |
FR2705361B1 (fr) | 1993-05-18 | 1995-08-04 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
US5679582A (en) | 1993-06-21 | 1997-10-21 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
NZ269156A (en) | 1993-07-13 | 1996-03-26 | Rhone Poulenc Rorer Sa | Defective recombinant adenovirus vector incapable of replicating autonomously in a target cell and its use in gene therapy |
CA2168202A1 (en) | 1993-07-30 | 1995-03-16 | Joseph Dougherty | Efficient gene transfer into primary lymphocytes |
US5830877A (en) | 1993-08-26 | 1998-11-03 | The Regents Of The University Of California | Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory |
US5474905A (en) * | 1993-11-24 | 1995-12-12 | Research Corporation Technologies | Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens |
FR2714830B1 (fr) | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FR2715847B1 (fr) | 1994-02-08 | 1996-04-12 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FR2716459B1 (fr) | 1994-02-22 | 1996-05-10 | Univ Paris Curie | Système hôte-vecteur utilisable en thérapie génique. |
WO1995026411A2 (en) | 1994-03-25 | 1995-10-05 | The Uab Research Foundation | Composition and methods for creating syngeneic recombinant virus-producing cells |
WO1995028494A1 (en) | 1994-04-15 | 1995-10-26 | Targeted Genetics Corporation | Gene delivery fusion proteins |
EP0804582A1 (en) * | 1994-05-16 | 1997-11-05 | The Uab Research Foundation | $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS |
US5773001A (en) | 1994-06-03 | 1998-06-30 | American Cyanamid Company | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
US5565204A (en) * | 1994-08-24 | 1996-10-15 | American Cyanamid Company | Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
FR2727679B1 (fr) | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
FR2730637B1 (fr) | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
US5670798A (en) * | 1995-03-29 | 1997-09-23 | North Carolina State University | Integrated heterostructures of Group III-V nitride semiconductor materials including epitaxial ohmic contact non-nitride buffer layer and methods of fabricating same |
US5792462A (en) | 1995-05-23 | 1998-08-11 | University Of North Carolina At Chapel Hill | Alphavirus RNA replicon systems |
WO1996039036A1 (en) | 1995-06-05 | 1996-12-12 | The University Of Alabama At Birmingham Research Foundation | Composition and methods for creating syngeneic recombinant virus-producing cells |
FR2741358B1 (fr) | 1995-11-17 | 1998-01-02 | Centre Nat Rech Scient | Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn |
US5987048A (en) * | 1996-07-26 | 1999-11-16 | Kabushiki Kaisha Toshiba | Gallium nitride-based compound semiconductor laser and method of manufacturing the same |
EP1770164B1 (en) * | 1996-10-31 | 2010-09-01 | Human Genome Sciences, Inc. | Streptococcus pneumoniae antigens and vaccines |
EP0942984A2 (en) * | 1996-11-12 | 1999-09-22 | Regents Of The University Of Minnesota | C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
DE69826124T3 (de) | 1997-06-30 | 2007-10-11 | Institut Gustave Roussy | Verabreichung der nukleinsäure in den quergestreiften muskel |
KR20010020570A (ko) | 1997-06-30 | 2001-03-15 | 자끄 사비나 | 다세포 진핵 생물 세포중으로 개선된 핵산 전달방법 및이를 위한 콤비네이션 |
WO1999001175A1 (en) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo |
US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
JPH1187504A (ja) * | 1997-09-12 | 1999-03-30 | Toshiba Corp | 半導体装置の製造方法及び配線の形成方法 |
AU9510598A (en) * | 1997-09-24 | 1999-04-12 | American Cyanamid Company | Human complement c3-degrading proteinase from (streptococcus pneumoniae) |
US6013937A (en) * | 1997-09-26 | 2000-01-11 | Siemens Aktiengesellshaft | Buffer layer for improving control of layer thickness |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
ES2284247T3 (es) | 1998-04-03 | 2007-11-01 | University Of Iowa Research Foundation | Metodos y productos para estimular el sistema inmunitario usando oligonucleotidos y citoquinas inmunoterapeuticos. |
US6233265B1 (en) * | 1998-07-31 | 2001-05-15 | Xerox Corporation | AlGaInN LED and laser diode structures for pure blue or green emission |
JP4673974B2 (ja) | 1998-09-30 | 2011-04-20 | ワイス・ホールディングズ・コーポレイション | アジュバントとしての変異コレラホロトキシン |
US6133589A (en) * | 1999-06-08 | 2000-10-17 | Lumileds Lighting, U.S., Llc | AlGaInN-based LED having thick epitaxial layer for improved light extraction |
EP1268774A2 (en) | 2000-03-21 | 2003-01-02 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in prokaryotes |
DE60144198D1 (de) * | 2000-12-28 | 2011-04-21 | Wyeth Llc | Rekombinantes schutzprotein aus streptococcus pneumoniae |
MXPA03009415A (es) * | 2001-04-16 | 2004-01-29 | Wyeth Corp | ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS. |
-
2001
- 2001-12-28 DE DE60144198T patent/DE60144198D1/de not_active Expired - Lifetime
- 2001-12-28 DK DK01996301.6T patent/DK1355918T5/da active
- 2001-12-28 EP EP01996301A patent/EP1355918B9/en not_active Expired - Lifetime
- 2001-12-28 ES ES01996301T patent/ES2359625T3/es not_active Expired - Lifetime
- 2001-12-28 CA CA002432426A patent/CA2432426A1/en not_active Abandoned
- 2001-12-28 WO PCT/US2001/049650 patent/WO2002053761A2/en active Application Filing
- 2001-12-28 MX MXPA03005386A patent/MXPA03005386A/es active IP Right Grant
- 2001-12-28 AU AU2002227450A patent/AU2002227450B2/en not_active Ceased
- 2001-12-28 EP EP10184194A patent/EP2402359A1/en not_active Withdrawn
- 2001-12-28 AT AT01996301T patent/ATE501161T1/de active
- 2001-12-28 CN CNB018215564A patent/CN100422210C/zh not_active Expired - Fee Related
- 2001-12-28 BR BR0116756-1A patent/BR0116756A/pt not_active IP Right Cessation
- 2001-12-28 JP JP2002555266A patent/JP4445200B2/ja not_active Expired - Fee Related
- 2001-12-28 US US10/433,385 patent/US7118756B2/en not_active Expired - Fee Related
- 2001-12-28 IL IL15572601A patent/IL155726A0/xx unknown
- 2001-12-28 KR KR10-2003-7008585A patent/KR20030074680A/ko active IP Right Grant
-
2006
- 2006-08-31 US US11/513,418 patent/US8124750B2/en not_active Expired - Fee Related
- 2006-08-31 US US11/513,417 patent/US8114417B2/en not_active Expired - Fee Related
-
2009
- 2009-06-18 JP JP2009145654A patent/JP2009201527A/ja active Pending
-
2012
- 2012-01-11 US US13/347,830 patent/US20120141522A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2359625T9 (es) | 2012-02-16 |
AU2002227450B2 (en) | 2008-02-28 |
KR20030074680A (ko) | 2003-09-19 |
CA2432426A1 (en) | 2002-07-11 |
BR0116756A (pt) | 2005-01-04 |
US20070129322A1 (en) | 2007-06-07 |
EP1355918A4 (en) | 2006-07-19 |
EP2402359A1 (en) | 2012-01-04 |
US7118756B2 (en) | 2006-10-10 |
JP4445200B2 (ja) | 2010-04-07 |
DE60144198D1 (de) | 2011-04-21 |
CN100422210C (zh) | 2008-10-01 |
US20120141522A1 (en) | 2012-06-07 |
JP2009201527A (ja) | 2009-09-10 |
DK1355918T5 (da) | 2012-02-20 |
WO2002053761A2 (en) | 2002-07-11 |
ES2359625T3 (es) | 2011-05-25 |
EP1355918B1 (en) | 2011-03-09 |
JP2005504501A (ja) | 2005-02-17 |
AU2002227450A2 (en) | 2002-07-16 |
US20040052816A1 (en) | 2004-03-18 |
ATE501161T1 (de) | 2011-03-15 |
US8124750B2 (en) | 2012-02-28 |
US8114417B2 (en) | 2012-02-14 |
IL155726A0 (en) | 2003-11-23 |
CN1529710A (zh) | 2004-09-15 |
EP1355918B9 (en) | 2012-01-25 |
MXPA03005386A (es) | 2004-04-20 |
US20070141085A1 (en) | 2007-06-21 |
EP1355918A2 (en) | 2003-10-29 |
WO2002053761A3 (en) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1355918T3 (da) | Rekombinant beskyttelsesprotein af streptococcus pneumoniae | |
NZ549873A (en) | Compounds and methods for treatment and diagnosis of chlamydial infection by stimulating an immune response | |
DE69940439D1 (de) | Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe | |
BR9812525A (pt) | Proteinase degradadora de complemento humano c3 de streptococcus pneumoniae | |
ATE217885T1 (de) | Antimikrobielle polypeptide | |
BR9914066A (pt) | Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae | |
NO964976L (no) | Kopolymer-1-forbedringer kopolymerpreparater | |
WO2002080939A8 (en) | Ionene polymers and their use as antimicrobial agents | |
DK0626452T3 (da) | Vaccine mod infektion af Streptococcus suis | |
CA2105057A1 (en) | Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man | |
WO2004069137A3 (de) | Verwendung von polyamino- und/oder polyammonium-polysiloxancopolymeren | |
WO2002090502A3 (en) | Highly conserved proteins from gram-positive bacteria | |
EP1019084A4 (en) | NEW ANTIMICROBIAL POLYPEPTIDES AND METHOD FOR THEIR USE. | |
DE69908885D1 (de) | NEUARTIGES AUS -i(PARASILURUS ASOTUS) ISOLIERTES ANTIMIKROBIELLES PEPTID UND SEINE VERWENDUNG | |
PL349320A1 (en) | Genes and proteins, and their use | |
WO2004076474A3 (en) | Polyethylene glycol modified interferon compositions and methods of use thereof | |
RU95105983A (ru) | Ингибиторы тромбина, способы их получения и фармацевтическая композиция на их основе | |
ITTO20010804A0 (it) | Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl | |
WO1998040497A3 (en) | An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method | |
EA200100701A1 (ru) | Белки наружной поверхности, их гены и их применение | |
WO2000029433A3 (en) | 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines | |
EP1815861A3 (en) | Ionene polymers and their use as antimicrobial agents | |
AP1679A (en) | Outer surface proteins, their genes, and their use. | |
BR0107799A (pt) | Proteìna de interação de wt1 wtip |